share_log

Aspira Womens Health Analyst Ratings

Aspira Womens Health Analyst Ratings

Aspira 女性健康分析師評級
Benzinga ·  2023/08/22 08:45
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/22/2023 102.9% Alliance Global Partners → $5.6 Initiates Coverage On → Buy
05/17/2023 63.04% Cantor Fitzgerald $2 → $4.5 Maintains Neutral
01/20/2023 -27.54% Cantor Fitzgerald $3 → $2 Downgrades Overweight → Neutral
03/29/2021 334.78% Truist Securities → $12 Initiates Coverage On → Buy
01/29/2021 262.32% Cantor Fitzgerald → $10 Initiates Coverage On → Overweight
10/30/2020 William Blair Initiates Coverage On → Outperform
日期 上行/下行 分析公司 目標價格變動 評級變動 之前/當前的評級
08/22/2023 102.9% 聯盟全球合作伙伴 → 5.6 美元 啓動覆蓋開啓 → 購買
05/17/2023 63.04% 坎託·菲茨傑拉德 $2 → 4.5 美元 維護 中立
01/20/2023 -27.54% 坎託·菲茨傑拉德 3 美元 → 2 美元 降級 超重 → 中性
03/29/2021 334.78% 信託證券 → 12 美元 啓動覆蓋開啓 → 購買
2021 年 1 月 29 日 262.32% 坎託·菲茨傑拉德 → 10 美元 啓動覆蓋開啓 → 超重
10/30/2020 威廉布萊爾 啓動覆蓋開啓 → 跑贏大盤

What is the target price for Aspira Womens Health (AWH)?

Aspira Womens Health(AWH)的目標價格是多少?

The latest price target for Aspira Womens Health (NASDAQ: AWH) was reported by Alliance Global Partners on August 22, 2023. The analyst firm set a price target for $5.60 expecting AWH to rise to within 12 months (a possible 102.90% upside). 3 analyst firms have reported ratings in the last year.

Alliance Global Partners於2023年8月22日公佈了Aspira Womens Health(納斯達克股票代碼:AWH)的最新目標股價。該分析公司將目標股價定爲5.60美元,預計AWH將在12個月內上漲至102.90%(可能上漲102.90%)。去年有3家分析公司公佈了評級。

What is the most recent analyst rating for Aspira Womens Health (AWH)?

Aspira Womens Health(AWH)的最新分析師評級是多少?

The latest analyst rating for Aspira Womens Health (NASDAQ: AWH) was provided by Alliance Global Partners, and Aspira Womens Health initiated their buy rating.

Aspira Womens Health(納斯達克股票代碼:AWH)的最新分析師評級由聯盟全球合作伙伴提供,Aspira Womens Health啓動了買入評級。

When is the next analyst rating going to be posted or updated for Aspira Womens Health (AWH)?

Aspira Womens Health(AWH)的下一份分析師評級何時發佈或更新?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aspira Womens Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aspira Womens Health was filed on August 22, 2023 so you should expect the next rating to be made available sometime around August 22, 2024.

分析師在進行了廣泛的研究後得出了股票評級,包括閱讀公開財務報表、與Aspira Womens Health的高管和客戶交談以及聽取業績電話會議。大多數分析師每三個月進行一次評級,因此每家公司每年應獲得4個評級。Aspira Womens Health的最後一個評級是在2023年8月22日提交的,因此你應該預計下一個評級將在2024年8月22日左右公佈。

Is the Analyst Rating Aspira Womens Health (AWH) correct?

分析師對Aspira女性健康(AWH)的評級是否正確?

While ratings are subjective and will change, the latest Aspira Womens Health (AWH) rating was a initiated with a price target of $0.00 to $5.60. The current price Aspira Womens Health (AWH) is trading at is $2.76, which is within the analyst's predicted range.

雖然評級是主觀的,並且會發生變化,但最新的Aspira Womens Health(AWH)評級最初的目標價爲0.00美元至5.60美元。Aspira Womens Health(AWH)的當前交易價格爲2.76美元,在分析師的預測區間內。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論